EGFR and cancer: Since EGFR signaling strongly depends on receptor mobility as outlined above and aberrant signaling of EGFR is associated with various cancers by promoting oncogenic signaling, this receptor has been widely investigated as a model system to explore how the nanoscale organization of the plasma membrane affects signaling function (Oda et al., 2005; Erazo-Oliveras et al., 2018).